Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon

British Journal of Cancer

Volumn 87, Issue 2, 2002, Pages 181-186

  Gogas, H ^a   Kefala, G ^a   Bafaloukos, D ^b   Frangia, K ^b   Polyzos, A ^a   Pectasides, D ^b   Tsoutsos, D ^b   Panagiotou, P ^b   Ioannovich, J ^b   Loukopoulos, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Hellenic Cooperative Oncology Group   (Greece)

Author keywords

Interferon; Melanoma; RT PCR; Tyrosinase mRNA

Indexed keywords

INTERFERON; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOLOGICAL RESPONSE MODIFIERS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERONS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 18544370090     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600419     Document Type: Article

References (18)

1. PCR detection of circulating melanocytes as a prognostic marker in patiens with melanoma
2. Separation of leucocytes from blood and bone marrow
3. Hematogenous spread of malignant melanoma cells in different stages of disease
4. Single-step method for RNA isolation by acid guanidium thiocianate-phenol-chloroform extraction
5. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment and recurrence from melanoma
6. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction
7. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
8. Adjuvant biotherapy with high dose interferon in high-risk melanoma patients (preliminary results)
9. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
10. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
11. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus
12. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long term clinically disease-flee melanoma patients
13. Polymerase Chain Reaction-based detection of circulating melanoma cells as en effective marker of tumor progression
14. Reverse transcriptase - Polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood
15. The analysis of tyrosinase -specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
16. Amplification of Melan A messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma
17. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
18. Detection of tyrosinase mRNA from the blood of melanoma patients